☆ 4.6 Review

Liver Transplantation in Hepatitis B/Hepatitis D (Delta) Virus Coinfected Recipients

TRANSPLANTATION (2022)

Related references

Note: Only part of the references are listed.

Article Transplantation

Liver Transplantation for Hepatitis D Virus in the United States: A UNOS Study on Outcomes in the MELD Era

Tatyana Kushner et al.

Summary: This study evaluated the outcomes of liver transplantation among HBV and HDV patients in the United States, finding that HDV patients were younger and had more severe liver disease characteristics compared to HBV patients. However, post-transplant survival was similar between HDV and HBV patients.

TRANSPLANTATION DIRECT (2022)

Add to Collection

Review Gastroenterology & Hepatology

The changing context of hepatitis D

Mario Rizzetto et al.

Summary: The global epidemiology of hepatitis D is changing with the widespread implementation of hepatitis B vaccination. In high-income countries, the epidemiology of chronic hepatitis D is dual, with distinct characteristics observed in endemic countries. Despite recent progress, therapeutic management of HDV remains unsatisfactory.

JOURNAL OF HEPATOLOGY (2021)

Add to Collection

Article Multidisciplinary Sciences

The hepatitis D virus in Italy. A vanishing infection, not yet a vanished disease

Gian Paolo Caviglia et al.

Summary: Although HDV infection is disappearing in Italy, it still has a medical impact on liver transplantation due to the presence of residual cases among native Italian patients. The study found that a significant proportion of native Italians with HDV infection had cirrhosis, and a majority remained HDV viremic even after follow-up. Hepatitis D played a disproportionate role in liver transplants compared to its minor prevalence in HBsAg-positive liver disorders in Italy.

JOURNAL OF ADVANCED RESEARCH (2021)

Add to Collection

Article Virology

Discontinuation of Passive Immunization Is Safe after Liver Transplantation for Combined HBV/HDV Infection

Ramin Raul Ossami Saidy et al.

Summary: This study examined the course of 36 patients after liver transplantation for combined HBV/HDV infection and found that discontinuation of HBIG did not lead to a higher recurrence rate of HBV/HDV infection or impaired overall survival.

VIRUSES-BASEL (2021)

Add to Collection

Review Gastroenterology & Hepatology

2020 position statement and recommendations of the European Liver and Intestine Transplantation Association (ELITA): management of hepatitis B virus-related infection before and after liver transplantation

Christophe Duvoux et al.

Summary: ELITA has proposed recommendations for the prevention of HBV recurrence after liver transplantation, emphasizing personalized prophylaxis strategies based on risk assessment. Different prophylactic options are recommended for low and high virological risk patients, with specific considerations for special populations such as HDV, HCC, and poorly adherent patients. The recommendations aim to provide a more rational and standardized approach to HBV prophylaxis across liver transplant programs.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2021)

Add to Collection

Article Gastroenterology & Hepatology

New therapies for hepatitis delta virus infection

Dimitri Loureiro et al.

Summary: Hepatitis delta virus (HDV) infection relies on hepatitis B virus (HBV) for replication, with 15 to 25 million people worldwide living with chronic HDV infection. Improving HBV vaccination coverage is key to reducing HDV prevalence. Treatment options include PEG-IFN α and the newly approved entry inhibitor, BLV.

LIVER INTERNATIONAL (2021)

Add to Collection

Article Surgery

Liver Transplantation: A 10-Year Low-Volume Transplant Center Experience in Kazakhstan

Jamilya Saparbay et al.

Summary: The liver transplantation program in Kazakhstan has conducted 64 liver transplantations between 2010 and 2020. The most common cause of end-stage liver disease was hepatitis B+hepatitis D infection. Patient survival rates were higher for recipients of a liver transplant from a living donor compared to those from a deceased donor.

ANNALS OF TRANSPLANTATION (2021)

Add to Collection

Review Gastroenterology & Hepatology

Hepatitis D virus and liver transplantation: Indications and outcomes

Haris Muhammad et al.

Summary: Hepatitis D virus relies on hepatitis B virus for replication and transmission, and chronic hepatitis D can lead to end stage liver disease. Pegylated interferon alpha is currently the only approved therapy, and liver transplantation is the only treatment option for end-stage liver disease. Data on the long-term impact of liver transplantation on HDV mainly come from international centers.

WORLD JOURNAL OF HEPATOLOGY (2021)

Add to Collection

Article Immunology

Estimating the Global Prevalence, Disease Progression, and Clinical Outcome of Hepatitis Delta Virus Infection

Zhijiang Miao et al.

JOURNAL OF INFECTIOUS DISEASES (2020)

Add to Collection

Review Gastroenterology & Hepatology

The global prevalence of hepatitis D virus infection: Systematic review and meta-analysis

Alexander J. Stockdale et al.

JOURNAL OF HEPATOLOGY (2020)

Add to Collection

Article Immunology

Hepatitis B Immunoglobulin discontinuation in long-term liver transplant patients

Eva Maria Dobrindt et al.

TRANSPLANT INFECTIOUS DISEASE (2020)

Add to Collection

Article Gastroenterology & Hepatology

Migratory flow and hepatitis delta infection in Italy: A new challenge at the beginning of the third millennium

Tommaso Stroffolini et al.

JOURNAL OF VIRAL HEPATITIS (2020)

Add to Collection

Review Virology

Infection by Hepatitis Delta Virus

John M. Taylor

VIRUSES-BASEL (2020)

Add to Collection

Review Gastroenterology & Hepatology

Prevalence and burden of hepatitis D virus infection in the global population: a systematic review and meta-analysis

Hai-Yan Chen et al.

GUT (2019)

Add to Collection

Article Immunology

Recurrence of Hepatitis D Virus in Liver Transplant Recipients With Hepatitis B and D Virus-Related Chronic Liver Disease

Ayfer Serin et al.

TRANSPLANTATION PROCEEDINGS (2019)

Add to Collection

Article Gastroenterology & Hepatology

Clinical and virological heterogeneity of hepatitis delta in different regions world-wide: The Hepatitis Delta International Network (HDIN)

Anika Wranke et al.

LIVER INTERNATIONAL (2018)

Add to Collection

Article Gastroenterology & Hepatology

Entecavir or tenofovir monotherapy prevents HBV recurrence in liver transplant recipients: A 5-year follow-up study after hepatitis B immunoglobulin withdrawal

Matteo A. Manini et al.

DIGESTIVE AND LIVER DISEASE (2018)

Add to Collection

Letter Gastroenterology & Hepatology

Are immunoglobulins against the HBsAg still needed in liver transplantation for hepatitis D?

Silvia Martini et al.

HEPATOLOGY (2018)

Add to Collection

Article Virology

Hepatitis D diagnostics:Utilization and testing in the United States

Parham Safaie et al.

VIRUS RESEARCH (2018)

Add to Collection

Article Surgery

2018 Annual Report of the European Liver Transplant Registry (ELTR)-50-year evolution of liver transplantation

Rene Adam et al.

TRANSPLANT INTERNATIONAL (2018)

Add to Collection

Article Surgery

Recurrence of Hepatitis B Infection in Liver Transplant Patients Receiving Long-Term Hepatitis B Immunoglobulin Prophylaxis

Susanne Beckebaum et al.

ANNALS OF TRANSPLANTATION (2018)

Add to Collection

Article Gastroenterology & Hepatology

Long-Term Outcomes of Entecavir Monotherapy for Chronic Hepatitis B After Liver Transplantation: Results up to 8 Years

James Fung et al.

HEPATOLOGY (2017)

Add to Collection

Article Gastroenterology & Hepatology

EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection

JOURNAL OF HEPATOLOGY (2017)

Add to Collection

Letter Immunology

Long-term nucleos(t)ide analog(s) monoprophylaxis in Delta coinfected liver transplant recipients

Lucio Caccamo

TRANSPLANT INFECTIOUS DISEASE (2017)

Add to Collection

Article Immunology

Short Course of Postoperative Hepatitis B Immunoglobulin Plus Antivirals Prevents Reinfection of Liver Transplant Recipients

Kavita Radhakrishnan et al.

TRANSPLANTATION (2017)

Add to Collection

Article Surgery

The Romanian National Program for Liver Transplantation - 852 Procedures in 815 Patients over 17 Years (2000-2017): A Continuous Evolution to Success

Irinel Popescu et al.

CHIRURGIA (2017)

Add to Collection

Article Immunology

Nucleos(t)ide analog(s) prophylaxis after hepatitis B immunoglobulin withdrawal against hepatitis B and D recurrence after liver transplantation

E. Cholongitas et al.

TRANSPLANT INFECTIOUS DISEASE (2016)

Add to Collection

Article Immunology

Hepatitis B Virus and Hepatitis D Virus Recurrence in Patients Undergoing Liver Transplantation for Hepatitis B Virus and Hepatitis B Virus Plus Hepatitis D Virus

B. Adil et al.

TRANSPLANTATION PROCEEDINGS (2016)

Add to Collection

Article Gastroenterology & Hepatology

Delta hepatitis within the Veterans Affairs medical system in the United States: Prevalence, risk factors, and outcomes

Tatyana Kushner et al.

JOURNAL OF HEPATOLOGY (2015)

Add to Collection

Meeting Abstract Gastroenterology & Hepatology

Liver transplantation for hepatitis B with delta coinfection: a single center experience

F. Tandoi et al.

JOURNAL OF VIRAL HEPATITIS (2015)

Add to Collection

Article Immunology

Tenofovir/entecavir monotherapy after hepatitis B immunoglobulin withdrawal is safe and effective in the prevention of hepatitis B in liver transplant recipients

I. Fernandez et al.

TRANSPLANT INFECTIOUS DISEASE (2015)

Add to Collection

Article Surgery

New nucleos(t)ide analogue monoprophylaxis after cessation of hepatitis B immunoglobulin is effective against hepatitis B recurrence

Evangelos Cholongitas et al.

TRANSPLANT INTERNATIONAL (2014)

Add to Collection

Article Gastroenterology & Hepatology

Living related liver transplantation for hepatitis B-related liver disease without hepatitis B immune globulin prophylaxis

Manav Wadhawan et al.

LIVER TRANSPLANTATION (2013)

Add to Collection

Article Gastroenterology & Hepatology

Rapid early HDV RNA decline in the peripheral blood but prolonged intrahepatic hepatitis delta antigen persistence after liver transplantation

Ingmar Mederacke et al.

JOURNAL OF HEPATOLOGY (2012)

Add to Collection

Review Gastroenterology & Hepatology

Epidemiology of Hepatitis D

Mario Rizzetto et al.

SEMINARS IN LIVER DISEASE (2012)

Add to Collection

Review Gastroenterology & Hepatology

Treatment of Chronic Delta Hepatitis

Cihan Yurdaydin

SEMINARS IN LIVER DISEASE (2012)

Add to Collection

Review Gastroenterology & Hepatology

Liver Transplantation in Delta Virus Infection

Bruno Roche et al.

SEMINARS IN LIVER DISEASE (2012)

Add to Collection

Review Gastroenterology & Hepatology

Clinical Features of Hepatitis D

Patrizia Farci et al.

SEMINARS IN LIVER DISEASE (2012)

Add to Collection

Article Gastroenterology & Hepatology

Current Status of Liver Transplantation for Hepatitis B Virus

Corinne Buchanan et al.

CLINICS IN LIVER DISEASE (2011)

Add to Collection

Article Biotechnology & Applied Microbiology

Hepatitis delta virus proteins repress hepatitis B virus enhancers and activate the alpha/beta interferon-inducible MxA gene

Virginie Williams et al.

JOURNAL OF GENERAL VIROLOGY (2009)

Add to Collection

Review Virology

Hepatitis Delta Virus RNA Replication

Chung-Hsin Tseng et al.

VIRUSES-BASEL (2009)

Add to Collection

Article Immunology

Role of lamivudine in the posttransplant prophylaxis of chronic hepatitis B virus and hepatitis delta virus coinfection

Lucio Caccamo et al.

TRANSPLANTATION (2007)

Add to Collection

Article Gastroenterology & Hepatology

Influence of hepatitis delta virus infection on morbidity and mortality in compensated cirrhosis type B

G Fattovich et al.

GUT (2000)

Add to Collection

© Peeref 2019-2024. All rights reserved.